Prime Medicine, Inc.
PRMENasdaqCIK 1894562HealthcareFiscal year ends Dec 31
Reports and events: 70 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0608:03 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-053883 |
| 2026-08-0608:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053878 |
| 2026-07-0808:02 ET | 8-K | 8.01 Other events | 0001628280-26-047590 |
| 2026-06-0816:10 ET | 8-K | 5.07 Shareholder vote results | 0001628280-26-041543 |
| 2026-05-0708:15 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-031726 |
| 2026-05-0708:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031719 |
| 2026-04-2308:35 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001628280-26-026697 |
| 2026-04-1608:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-26-025372 |
| 2026-03-0308:19 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001628280-26-013569 |
| 2026-03-0308:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-013565 |
| 2026-01-1208:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001773 |
| 2025-11-0707:35 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001628280-25-050422 |
| 2025-11-0707:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-050415 |
| 2025-09-0808:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001894562-25-000056 |
| 2025-08-1121:48 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001072613-25-000536 |
| 2025-08-0708:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001628280-25-038619 |
| 2025-08-0708:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-038617 |
| 2025-08-0516:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001628280-25-037840 |
| 2025-07-3117:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-037076 |
| 2025-07-3016:04 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-036705 |
| 2025-07-1516:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-25-034971 |
| 2025-07-1416:38 ET | DEF 14A | Proxy statementPeriod 2025-08-01 | 0001193125-25-158716 |
| 2025-06-0516:11 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-25-029646 |
| 2025-05-1909:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-122156 |
| 2025-05-0808:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-023486 |
| 2025-05-0808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023482 |
| 2025-04-2206:07 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001628280-25-018704 |
| 2025-03-1807:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-056122 |
| 2025-02-2808:13 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-008884 |
| 2025-02-2808:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008873 |
| 2025-01-1308:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001244 |
| 2024-11-2217:32 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000898 |
| 2024-11-1216:10 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-047130 |
| 2024-11-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-047119 |
| 2024-10-2408:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-043500 |
| 2024-09-3007:38 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-041541 |
| 2024-08-0808:26 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-035893 |
| 2024-08-0808:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-035886 |
| 2024-06-1216:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-027816 |
| 2024-05-2116:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001628280-24-024530 |
| 2024-05-1008:22 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-022473 |
| 2024-05-1008:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-022466 |
| 2024-04-2916:03 ET | DEF 14A | Proxy statementPeriod 2024-06-12 | 0001628280-24-018977 |
| 2024-03-0108:04 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-008116 |
| 2024-03-0108:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-008113 |
| 2024-02-2221:31 ET | SC 13D | Ownership report, active investor | 0001072613-24-000265 |
| 2024-02-1606:23 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-038016 |
| 2024-02-1416:12 ET | 8-K | 2.02 Results of operations | 0001628280-24-004785 |
| 2024-01-0808:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-003924 |
| 2024-01-0517:03 ET | 8-K | 8.01 Other events | 0001628280-24-000676 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:06 ET. Listed shows no prices and gives no investment advice.